@Dosdogs So to cut to the chase, you are accusing IMU management...

@Dosdogs So to cut to the chase, you are accusing IMU management of misleading shareholders by withholding material trial information. Further, the so-called incriminating evidence of censoring was published and available for analysis by anyone familiar with clinical trials and is hiding in plain sight. You say that IMU is not waiting for any more patients which directly contradicts what Leslie Chong has said and whats more, pharma companies have put their names to trial activities. Then you say you hold shares in that same company .... why?

Oh and can we get one other semantic issue fixed ... it is HER-VAXX. Perhaps you should examine some of the assumptions you have built into your assertions.